ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 275

Predictive Factors of Cytomegalovirus Infection in Patients with Connective Tissue Diseases Treated with Immunosuppressive Drugs

Yusuke Yoshida1, Hiroki Kohno2, Katsuhiro Oi3, Tadahiro Tokunaga3, Tatsuomi Kuranobu3, Takaki Nojima4, Shintaro Hirata3 and Eiji Sugiyama1, 1Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 2Hiroshima Prefectural Hospital, Hiroshima, Japan, 3Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 4Clinical Immunology and Rheumatolog, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Connective tissue diseases, immunodeficiency and infection

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cytomegalovirus (CMV) infections occur frequently in immunocompromised patients. This disease will be fatal if proper treatment is not done. Therefore, in the treatment of connective tissue disease (CTDs), care should be taken while paying attention to the onset of cytomegalovirus infection. The purpose of this study is to clarify the predictors of CMV infection that developed in patients undergoing immunosuppressive treatment.

Methods: All CTD patients who were diagnosed as a CMV infection from January 2009 to March 2017 at our hospital were retrospectively reviewed. The diagnosis of CMV was made by clinical symptoms, radiological findings, the presence of CMV pp65 antigen in polymorphonuclear leukocyte (C7-HRP) and pathological findings of organ specimen. We compared the sequential changes in laboratory data between one month before diagnosis and at diagnosis. The differences in laboratory data between the survivors and non-survivors were also compared. Statistical analyses were performed using XLSTAT.

Results: A total of 20 patients were diagnosed with CMV infection (12 bone marrow suppression; 4 pneumonia; 2 enteritis; 1 genital ulcer; and 1 retinitis) and enrolled in this study. The mean age was 67.9 years old and 60% of patients was female. The CTDs of patients as follows: dermatomyositis (25%), adult-onset Still’s disease (15%), and microscopic polyangiitis (15%). All patients were positive for CMV pp65 (mean C7-HRP: 287.6 ± 510.0/50,000 WBC), who were treated with a moderate to high dose of glucocorticoids (mean prednisolone dose: 33.4 ± 15.9 mg/day). When compared laboratory data between one month before diagnosis and at diagnosis, reduction of leukocyte cells, lymphocytes, platelet counts and IgG levels were predictive for occurring CMV infection. Among them, lymphopenia was critical for distinguishing between survivors and non-survivors.

Conclusion: The decreased in the leukocyte, lymphocyte, platelet, and IgG levels are important predictive factors for CMV infection in CTDs. Among them, decreased lymphocytes counts is a critical predictive factor for life threatening condition.


Disclosure: Y. Yoshida, None; H. Kohno, None; K. Oi, None; T. Tokunaga, None; T. Kuranobu, None; T. Nojima, None; S. Hirata, None; E. Sugiyama, None.

To cite this abstract in AMA style:

Yoshida Y, Kohno H, Oi K, Tokunaga T, Kuranobu T, Nojima T, Hirata S, Sugiyama E. Predictive Factors of Cytomegalovirus Infection in Patients with Connective Tissue Diseases Treated with Immunosuppressive Drugs [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/predictive-factors-of-cytomegalovirus-infection-in-patients-with-connective-tissue-diseases-treated-with-immunosuppressive-drugs/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-factors-of-cytomegalovirus-infection-in-patients-with-connective-tissue-diseases-treated-with-immunosuppressive-drugs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology